Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

Jan 19, 2021 16:05 ET
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational neuromodulator product, DaxibotulinumtoxinA for Injection, today announced new hire grants totaling an aggregate of 75,400 inducement restricted stock awards (“RSAs”) to 15 employees. The RSAs vest over four years, with 25% of the underlying shares vesting on each of the four anniversaries of the applicable vesting commencement date, subject to the new employee's continued service relationship with Revance through the applicable vesting dat...
Jan 19, 2021 16:05 ET
SITE Centers Corp. Announces Tax Allocations of 2020 Dividend Distributions
SITE Centers (NYSE: SITC) today announced the tax allocations of 2020 distributions on its common shares and two series of preferred shares....
Jan 19, 2021 16:05 ET
Solaris Oilfield Infrastructure Issues Operational Update and Schedules Fourth Quarter and Full Year 2020 Results Conference Call
Solaris Oilfield Infrastructure, Inc. (NYSE:SOI) (“Solaris” or the “Company”) announced today it expects its fully utilized proppant silo system count in the fourth quarter of 2020 to increase 20-25% from third quarter 2020. This compares to the Company’s previous expectation for a flat to modestly higher level of activity....
Jan 19, 2021 16:05 ET
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2020 results after the financial markets close on Wednesday, February 24, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2020 financial and operating results....
Jan 19, 2021 16:03 ET
Perion Pre-Announces Fourth Quarter and Full Year 2020 Results
Perion Network Ltd. (NASDAQ: PERI), a global advertising technology company that delivers its Synchronized Digital Branding solution across the three main pillars of digital advertising - ad search, social media and display / video / CTV advertising – today announced preliminary results for the fourth quarter and full year 2020. Management now expects to exceed the previously announced guidance for both revenue and Adjusted EBTIDA. Additionally, the Company has pre-announced anticipated results for GAAP EPS and non-GAAP EPS....
Jan 19, 2021 16:02 ET
Conn’s HomePlus to Join Longview Mall Demonstrating Adaptive Reuse Progress
Washington Prime Group Inc. (NYSE: WPG) today announced that Conn’s HomePlus, specialty retailer of furniture, mattresses, home appliances and consumer electronics, will join the dynamic tenant lineup at Longview Mall, in Longview, Texas. As the only hybrid shopping center in the market, with both enclosed and open air formats, and situated among Longview’s dynamic retail and entertainment corridor, Longview Mall is the retail powerhouse in East Texas....
Jan 19, 2021 16:01 ET to Webcast Fourth Quarter 2020 Financial Results Conference Call, Inc. (NASDAQ: AMZN) announced today that it will hold a conference call to discuss its fourth quarter 2020 financial results on February 2, 2021 at 2:30 p.m. PT/5:30 p.m. ET....
Jan 19, 2021 16:01 ET
Interactive Brokers Group Announces 4Q2020 Results
Interactive Brokers Group, Inc. (Nasdaq: IBKR), an automated global electronic broker, reported diluted earnings per share of $0.81 for the quarter ended December 31, 2020 compared to $0.57 for the same period in 2019, and adjusted diluted earnings per share of $0.69 for this quarter compared to $0.58 for the year-ago quarter....
Jan 19, 2021 16:01 ET
National Storage Affiliates Trust Announces Date of its Fourth Quarter 2020 Earnings Release and Conference Call
National Storage Affiliates Trust (“NSA” or the “Company”) (NYSE: NSA) today announced the Company will release financial results for the three months ended December 31, 2020 after market close on Monday, February 22, 2021. NSA will host a conference call to discuss its financial results, current market conditions and future outlook at 12:00 p.m. Eastern Time on Tuesday, February 23, 2021. Following prepared remarks, management will accept questions from registered financial analysts. All other participants are encouraged to listen to the call via webcast using the link found on the Company’s ...
Jan 19, 2021 16:01 ET
Perion Network Ltd. Announces Launch of Proposed Follow-on Offering of Ordinary Shares
Perion Network Ltd. (NASDAQ: PERI), a global advertising technology company that delivers its Synchronized Digital Branding solution across the three main pillars of digital advertising – ad search, social media and display / video / CTV advertising – today announced that it has launched a proposed follow-on public offering of approximately $50 million of its ordinary shares. The ordinary shares are being offered by the Company pursuant to an effective shelf registration statement on file with the Securities and Exchange Commission (the “SEC”). In connection with the offering, the Company expe...
Jan 19, 2021 16:01 ET
Syros Announces Proposed Offering of Common Stock
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, announced today that it is offering to sell shares of its common stock in an underwritten public offering. The proceeds of the offering are expected to be used to fund the development of Syros’ ongoing clinical and preclinical programs, and for working capital and other general corporate purposes. All of the shares in the offering are to be sold by Syros. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may b...
Jan 19, 2021 16:00 ET
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 First Quarter Results
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 4, 2021, at 4:30 p.m. EST to discuss its financial results for the fiscal first quarter ended December 31, 2020....
Jan 19, 2021 16:00 ET
First Cohort of Black Corporate Board Readiness Professionals Convenes at Santa Clara University
Seasoned executives from the realms of high tech, entertainment, fashion, finance, professional sports and more have joined the inaugural cohort of Santa Clara University’s new Black Corporate Board Readiness program....
Jan 19, 2021 16:00 ET
Ginseng Market Research Report - Global Forecast to 2024 - Cumulative Impact for COVID-19 Recovery
The Ginseng will register an incremental spend of about USD 626.74 million, growing at a CAGR of 4.16% from 2020-2024. A targeted strategic approach to Ginseng market sourcing can unlock several opportunities for buyers. This report offers market impact and new opportunities created due to the COVID-19 pandemic.
Jan 19, 2021 16:00 ET
New Cutting Tool Inserts Market Research during 2021-2025 | Market Impact Analysis for the New Normal |Technavio
The new cutting tool inserts market research from Technavio indicates negative growth in the short term as the business impact of COVID-19 spreads....
Jan 19, 2021 16:00 ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Penumbra, Inc. (PEN) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Penumbra, Inc. (“Penumbra” or the “Company”) (NYSE:
Jan 19, 2021 15:56 ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Penumbra, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. (“Penumbra” or “the Company”) (NYSE:
Jan 19, 2021 15:54 ET
Nanotronics Unveils nTelligence, Its Fourth Generation of Artificial Intelligence Software
Nanotronics, developer of the world’s most advanced robotic industrial microscope that combines AI, automation, and sophisticated imaging for industrial inspection, is announcing the release of its fourth generation of artificial intelligence software, nTelligence™....
Jan 19, 2021 15:50 ET
Prosetta Biosciences Announces Novel Solution to COVID-19 Crisis
Prosetta Biosciences, a San Francisco biotechnology company, has developed novel small-molecule drugs that research indicates are effective not only against the COVID-19 virus, but against other virus families that cause respiratory disease, including influenza and the common cold – without the liability of drug resistance development....
Jan 19, 2021 15:45 ET
EDF Renewables North America Announces Commercial Operations at Maverick 1 and Maverick 4 Solar Projects
EDF Renewables North America today announced the completion and commercial operation of the Maverick 1 (173.4 MWdc) and Maverick 4 (135.9 MWdc) Solar Projects. Maverick 1 provides 125 MWac of electricity to Southern California Edison under a 15-year Power Purchase Agreement (PPA), while Maverick 4 supplies 100 MWac energy and renewable ...